Alopecia Areata: Diagnosis, Treatment, and Steps to Take – NIAMS (NIH)

Receiving a diagnosis of alopecia areata can be disorienting — especially because many patients spend months or years without a clear explanation for their hair loss. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (NIH), provides one of the most reliable and patient-accessible guides to understanding what happens after diagnosis. This page, titled "Diagnosis, Treatment, and Steps to Take," is specifically designed to answer the practical questions that crowd a patient's mind in the weeks following a diagnosis.

NIAMS explains that alopecia areata is diagnosed primarily by clinical examination — a dermatologist or other specialist evaluates the pattern of hair loss, may examine hair follicles under a dermoscope, and in some cases takes a scalp biopsy to confirm the diagnosis. The page also explains when additional blood tests might be ordered, since alopecia areata is associated with other autoimmune conditions including thyroid disease, and early detection of those co-occurring conditions is important for overall health management.

On treatment, the NIAMS guide covers the full spectrum of current options in plain language. These include corticosteroid injections into the scalp (one of the most commonly used first-line treatments for patchy alopecia), topical corticosteroids applied to affected areas, topical immunotherapy (a technique that deliberately triggers a mild allergic reaction to stimulate hair regrowth), and minoxidil. The page also addresses JAK inhibitors — a newer class of medications that have shown significant promise for moderate to severe alopecia areata — and explains how patients can discuss eligibility for these newer treatments with their dermatologist.

Importantly, the page includes a "Steps to Take" section that translates clinical information into real-world guidance. Patients are encouraged to work with a dermatologist who has experience treating alopecia areata, to discuss the emotional and psychological impact of hair loss with their healthcare provider, and to connect with patient support communities. NIAMS acknowledges that hair loss from alopecia areata — while not medically dangerous — can have a profound effect on self-image, mental health, and quality of life, and it treats this dimension of the condition with appropriate seriousness.

Because this resource comes directly from NIH, it is updated regularly as treatment evidence evolves and carries the credibility of the U.S. federal health research enterprise. It is free, requires no registration, and is written at a level accessible to patients without medical training. Whether you were recently diagnosed or have been living with alopecia areata for years and want to understand newer treatment options, this is an authoritative and genuinely useful page to bookmark and share with your care team.